Back to Browse Journals » Substance Abuse and Rehabilitation » Volume 1

Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse

Authors Li-Tzy Wu

Published 16 November 2010 Volume 2010:1 Pages 5—11

DOI http://dx.doi.org/10.2147/SAR.S14898

Review by Single-blind

Peer reviewer comments 3

Li-Tzy Wu*
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA
*Li-Tzy Wu is the Editor-in-Chief of Substance Abuse and Rehabilitation

Abstract: Alcohol, tobacco, and illegal drug use are pervasive throughout the world. Substance use problems are among the major contributors to the global disease burden, which includes disability and mortality. The benefits of treatment far outweigh the economic costs. Despite the availability of treatment services, however, the vast majority of people with substance use disorders do not seek or use treatment. Barriers to and unmet need for evidence-based treatment are widespread even in the United States. Women, adolescents, and young adults are especially vulnerable to adverse effects from substance abuse, but they face additional barriers to getting evidence-based treatment or other social/medical services. Substance use behaviors and the diseases attributable to substance use problems are preventable and modifiable. Yet the ever-changing patterns of substance use and associated problems require combined research and policy-making efforts from all parts of the world to establish a viable knowledge base to inform for prevention, risk-reduction intervention, effective use of evidence-based treatment, and rehabilitation for long-term recovery. The new international, open-access, peer-reviewed Substance Abuse and Rehabilitation (SAR) journal strives to provide an effective platform for sharing ideas for solutions and disseminating research findings globally. Substance use behaviors and problems have no boundaries. The journal welcomes papers from all regions of the world that address any aspect of substance use, abuse/dependence, intervention, treatment, and policy. The “open-access” journal makes cutting edge knowledge freely available to practitioners and researchers worldwide, and this is particularly important for addressing the global disease burden attributable to substance abuse.

Keywords: global burden of disease, rehabilitation, substance abuse, substance use disorders

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000–2011: results from the Diabetes Impact Study 2013

Green A, Sortsø C, Jensen PB, Emneus M

Clinical Epidemiology 2015, 7:421-430

Published Date: 23 October 2015

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S

Breast Cancer: Targets and Therapy 2015, 7:163-164

Published Date: 29 June 2015

Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition

Zaccaria A, Roux-Dalvai F, Bouamrani A, Mombrun A, Mossuz P, Monsarrat B, Berger F

International Journal of Nanomedicine 2015, 10:1869-1883

Published Date: 9 March 2015

In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice

Abu N, Mohamad NE, Yeap SK, Lim KL, Akhtar MN, Zulfadli AJ, Beh BK, Abdullah MP, Omar AR, Alitheen NB

Drug Design, Development and Therapy 2015, 9:1401-1417

Published Date: 6 March 2015

2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model

Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ

International Journal of Nanomedicine 2014, 9:3601-3610

Published Date: 30 July 2014

Entrapment in phospholipid vesicles quenches photoactivity of quantum dots

Generalov R, Kavaliauskiene S, Westrøm S, Chen W, Kristensen S, Juzenas P

International Journal of Nanomedicine 2011, 6:1875-1888

Published Date: 7 September 2011

Waiting for surgery from the patient perspective

Tracey Carr, Ulrich Teucher, Jackie Mann, Alan G Casson

Psychology Research and Behavior Management 2009, 2:107-119

Published Date: 14 October 2009

Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture

Jinzhong Wang, Nicole M Plourde, Nicole Iverson, Prabhas V Moghe, Kathryn E Uhrich

International Journal of Nanomedicine 2007, 2:697-705

Published Date: 15 January 2008

Treatment of phantom bite syndrome with milnacipran - a case series

Akira Toyofuku, Toshihiro Kikuta

Neuropsychiatric Disease and Treatment 2006, 2:387-390

Published Date: 15 September 2006